Free Republic

Greetings FRiends, I know, I know. It's a little crazy asking for medical feedback on the web, but I always trust this community to give me unfiltered and personal experience. I suppose you could say that I am somewhat incredulous when it comes to some of the big, pharma-sponsored websites. I realize that this is in NO WAY scientific. My wife has been ill for the last year; extreme fatigue and soreness in her joints. It is some kind of rheumatoid arthritis. Her doctor has treated her with numerous conventional drugs; methotextrate and prednisone. She's had mixed results. Her doctor...

AP MEDICAL WRITER CHICAGO -- Rheumatoid arthritis patients taking Humira or Remicade face triple the risk of developing several kinds of cancer and double the risk of getting serious infections, a study led by the Mayo Clinic found. The analysis builds on previous reports about the risks associated with Abbott Laboratories' Humira and Centocor's Remicade. But the earlier research focused mostly on one kind of cancer - lymphoma - and infections such as tuberculosis and pneumonia. The new study found an apparent link to other cancers, too, including skin, gastrointestinal, breast and lung tumors. It also quantifies the risks and...

Centocor Warns Doctors About Heightened Lymphoma Risk With Patients Who Take Remicade The Associated Press WASHINGTON Oct. 7, 2004 — Patients taking Remicade for rheumatoid arthritis suffered a type of cancer, lymphoma, at three times the rate of the general public, manufacturer Centocor warned doctors on Thursday. Centocor, a subsidiary of Johnson & Johnson, said the lymphoma incidence rate was six times higher among all patients who took the monoclonal antibody in completed clinical trials. Experts said such toxic outcomes, however, are still rare, and that the new drugs, on balance, work markedly better than older medications, without such side...